APA

Boekholdt S. M., Sacks F. M., Jukema J. W., Shepherd J., Freeman D. J., McMahon A. D., Cambien F., Nicaud V., de Grooth G. J., Talmud P. J., Humphries S. E., Miller G. J., Eiriksdottir G., Gudnason V., Kauma H., Kakko S., Savolainen M. J., Arca M., Montali A., Liu S., Lanz H. J., Zwinderman A. H., Kuivenhoven J. A. & Kastelein J. J. P. (20050622). Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. : Circulation.

Chicago

Boekholdt S M, Sacks F M, Jukema J W, Shepherd J, Freeman D J, McMahon A D, Cambien F, Nicaud V, de Grooth G J, Talmud P J, Humphries S E, Miller G J, Eiriksdottir G, Gudnason V, Kauma H, Kakko S, Savolainen M J, Arca M, Montali A, Liu S, Lanz H J, Zwinderman A H, Kuivenhoven J A and Kastelein J J P. 20050622. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. : Circulation.

Harvard

Boekholdt S. M., Sacks F. M., Jukema J. W., Shepherd J., Freeman D. J., McMahon A. D., Cambien F., Nicaud V., de Grooth G. J., Talmud P. J., Humphries S. E., Miller G. J., Eiriksdottir G., Gudnason V., Kauma H., Kakko S., Savolainen M. J., Arca M., Montali A., Liu S., Lanz H. J., Zwinderman A. H., Kuivenhoven J. A. and Kastelein J. J. P. (20050622). Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. : Circulation.

MLA

Boekholdt S M, Sacks F M, Jukema J W, Shepherd J, Freeman D J, McMahon A D, Cambien F, Nicaud V, de Grooth G J, Talmud P J, Humphries S E, Miller G J, Eiriksdottir G, Gudnason V, Kauma H, Kakko S, Savolainen M J, Arca M, Montali A, Liu S, Lanz H J, Zwinderman A H, Kuivenhoven J A and Kastelein J J P. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. : Circulation. 20050622.